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Objectives: This study aimed to characterize subchondral bone damages of knee osteoarthritis (OA) pa-
tients in presence of the comorbidities, i.e., hypertension and type 2 diabetes mellitus (T2DM).
Methods: A total of 43 patients with advanced stage of primary knee OAwere recruited, and tibial plateau
specimenswere collected during surgerywith informed consent. The specimenswere processed formicro-
CT and histological examination to assess the severity of subchondral bone damages. The presence of the
comorbiddisease, e.g., hypertensionandT2DM,and thedata on covariates, suchas the age, genderandbody
mass index (BMI), were taken into account in a multi-variable linear regression model to explore the po-
tential effect of the comorbidities on subchondral bone damages in knee OA after adjusting the covariates.
Results: As compared to 15 subjects without the comorbidities, signiﬁcant bone loss was observed at
subchondral plate in 28 knee OA patients with hypertension and T2DM, in terms of the lower bone
mineral density (BMD) (P ¼ 0.034) and higher porosity (P ¼ 0.032) on the medial portion of tibial
plateau. After adjusting the age, gender and BMI, the presence of hypertension or T2DM was included in
a regression model to explain in part the decreased BMD (r2 ¼ 0.551, P ¼ 0.004) and increased porosity
(r2 ¼ 0.545, P ¼ 0.003) at subchondral plate in knee OA.
Conclusion: Our ﬁndings suggest the biological link between bone loss at subchondral bone plate in knee
OA and the comorbid diseases, i.e., hypertension and T2DM, which prompt the needs for a large-scale
cohort study to conﬁrm the causality.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Knee osteoarthritis (OA) is the most common form of joint dis-
orders and a leading cause of walking disability among the older
adultswithapredictionof67millionOApatients in theUnitedStates
by20301. KneeOA isnotonlyaproblemof articular cartilage, but also
a whole joint disease, involving the other joint tissues, such as
subchondral bone2. For example, subchondral bone provides me-
chanical support and nutrition supply to overlying articular carti-
lage; subchondral bone and articular cartilage act as a unit to
maintain the structural and functional integrity of joint3,4. In addi-
tion, there is mount evidence showing that subchondral osteoblasts
in OA altered the cellular behavior of articular chondrocytes5e10. All
these ﬁndings support the notion that subchondral boneK.Y. Chiu, Li Shu Fan Medical
New Clinical Building, Queen
259; Fax: 852-28174392.
s Research Society International. Pdisturbance plays an important role in pathomechanism of OA and
contributes to the progression of disease11.
The etiology of OA is idiopathic and multifactorial. Aging,
menopause, obesity and genetic variations have been identiﬁed as
the major risk factors in the pathogenesis of knee OA1215. Meta-
bolic syndrome, including hypertension and Type 2 diabetes mel-
litus (T2DM), are frequently encountered comorbidities in the
elderly patients with knee OA. It was reported that there was
around 55% of knee OA patients of over 65 years old having hy-
pertension and 13% of them showing T2DM16. Hence, there is
growing research interest recently on the role of metabolic syn-
drome in the pathomechanism of knee OA among the elderly
persons17. The intimate relationship between knee OA and meta-
bolic syndrome signiﬁcantly contributes to themortality of patients
compared to generation population18. The walking disabilities of
OA knees have been identiﬁed as a major risk factor for the death of
elderly patients with T2DM and cardiovascular diseases18.
Although atheromatous vascular disease and diabetes were once
speculated in the pathogenesis of OA19e21, the exact impact of these
comorbidities, such as hypertension and T2DM, on the severity ofublished by Elsevier Ltd. All rights reserved.
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As previously reported, high blood pressure was associated with
the low bone mass and high risk of fractures in elderly persons23e
25. In T2DM patient, bone quality was also reduced with high risk of
fracture26, yet bone mineral density (BMD) increased in lumbar
spine, hip and radius in patients27. We hypothesized that hyper-
tension and T2DM as the comorbidities could interfere with sub-
chondral bone remodeling, and aggravate the severity of OA17.
Because of no prior knowledge on the relationship of sub-
chondral bone damages in knee OA with its comorbidities, we
initially proposed a cost-effective cross-sectional study to evaluate
the subchondral bone damages in knee OA in presence or absence
of hypertension and T2DM. Then we further investigated the
possible effect of these comorbidities on subchondral bone mass
and microstructure in knee OA after adjusting covariates, i.e., the
age, gender and BMI of patients. The ﬁndings generated from this
study would build up a solid scientiﬁc foundation for a large-scale
cohort study to test our hypothesis.
Patients and methods
Study design
The ethic committee of authors’ institute proved all the exper-
imental procedures in this study (Ref Nr: UW-09368). An experi-
enced orthopaedic specialist (CHY) recruited a total of 43 patients
of primary knee OA, and collected tibial plateau specimens during
total knee replacement surgery with informed consent from
February to October 2012 in authors’ institute (10 male, 33 females,
63e85 years old). The subjects were screened before recruitment;
the patients with the early-onset of knee OA prior to 40 years old,
history of knee joint trauma, infection and other rheumatic dis-
eases, such as gout etc., were not included in the current study. Two
subjects with multiple myeloma or osteoporosis on the treatment
of alendronate were excluded after initial screening. The knee OA
patients were then divided into different groups for comparisons
according to the presence or absence of hypertension and T2DM.
Clinical assessments
The severity of knee OA was assessed by the experienced or-
thopaedic surgeons (CHY, KYC) in our outpatient clinic prior toTable I
Demographic and clinical assessments of knee OA patients*
Parameters Comorbidities o
No hypertension
Number of patients 15
Gender (M: male; F: female) 3 (M), 12 (F)
Age 69  9 (58e82)
Body Mass Index (BMI, kg/m2) 27  4 (23-36)
Standing X-ray KellgreneLawrance (KeL) grade 8 (Grade 3), 7 (G
Knee Society Knee Score Pain (0e50) 23  8 (10 w 30
Passive range of motion (0e25) 21  3 (15 w 24
Stability (0e25) 23  4 (15 w 25
Fixed ﬂexion contracture (15 to 0) 1  1 (2w 0
Extension lag (15 to 0) 0  0 (0 w 0)
Alignment (20 to 0) 16  7 (20 w
Sum 44  19 (0e59)
Knee Society Functional
Assessment
Walking (0e50) 27  8 (20 w 40
Stairs (0e50) 30  0 (30 w 30
Aids (20 to 0) 5  0 (5 w 
Sum 52  8 (45e65)
All data were expressed as mean  standard deviation and range in the bracket. The com
among the groups of patients in presence or absence of hypertension and T2DM using on
T2DM: type 2 diabetes mellitus.
* The data of 1 patients having T2DM only were listed in supplementary materials butsurgery, The radiographic severity of OA knee was graded using
KellgreneLawrence (KeL) system on plain X-radiograph, and the
functional disability of OA knee was routinely examined using knee
society knee score (KSKS) and functional scale (KSFS)28.
The diagnosis of essential hypertension and T2DM was taken
from clinical record. The diagnosis is made in our institute ac-
cording to “the Seventh Report of the Joint National Committee on
prevention, detection, evaluation, and treatment of high blood
pressure” and “WHO report on the diagnosis and classiﬁcation of
diabetes mellitus”. In the current study, essential hypertension was
deﬁned as blood pressure over 140/90 mmHg or previous history of
essential hypertension on the medication; T2DM was deﬁned as a
single raised glucose reading with symptoms or history of T2DM on
medication or with the documented complications.
The data on covariates, such as the patients’ age, gender and
BMI, were taken from clinical records in authors’ institute. Results
of physical examination, e.g., systolic and blood pressure moni-
toring, and the clinical biochemistry tests of fast glucose test, cal-
cium/phosphate metabolism, liver and kidney function, which
were performed within one week prior to the surgery, were also
collected.
Micro-CT evaluation
The serial scans of tibial specimens was performed under a mCT
scanner (SkyScan 1,076, Kontich, Belgium) with the following
scanning parameters: 18 mm isotropic voxel size, 55 kV voltage,
109 mA current, 200 ms integration time and 4,000 projections. The
microstructure of subchondral plate and trabecular bone was
clearly visible in the 2D reconstructed images and separately for
analyses. Generally, they were converted into discrete binary ob-
jects by the global thresholding and binarisation procedures com-
bined with image ﬁltering such as despeckle to remove noise, and
then processed for 3Dmeasurement in SkyScan CTAn software. The
surface rendered 3D models were created for visualization via the
SkyScan CTVol software.
Subchondral bone in the central one third of medial or lateral
tibial plateau was chosen as the region of interest for analyses. The
parts of subchondral plate and trabecular bone underneath were
analyzed respectively. The irregular boundary of subchondral plate
was drawn with the aid of the edge detection program in MAT-
LABR2010a. Brieﬂy, the boundaryof binary objectswas detected in
the micro-CT images after segmentation. The edges of subchondralf knee OA patients
no T2DM Hypertension, No T2DM Hypertension and T2DM P value
15 12 /
5 (M), 10 (F) 3 (M), 9 (F) 0.037*
72  10 (52e85) 71  9 (52e86) 0.662#
28  4 (23e39) 25  3 (18e27) 0.257#
rade 4) 6 (Grade 3), 9 (Grade 4) 5 (Grade 3), 7 (Grade 4) 0.535*
) 22  9 (10 w 30) 26  11 (10 w 45) 0.652^
) 18  4 (12 w 25) 18  4 (10 w 24) 0.238^
) 21  7 (0 w 25) 24  4 (15 w 25) 0.645^
) 4  4 (15 w 0) 3  5 (15 w 0) 0.152^
0  1 (5w 0) 12 (5w 0) 0.417^
0) 19  3 (20 w 9) 13  10 (20 w 0) 0.102^
36  17 (0 w 61) 51  21 (20 w 87) 0.163^
) 22  4 (20 w 30) 20  5 (10 w 30) 0.051^
) 26  9 (0 w 30) 24  15 (0 w 40) 0.487^
5) 4  2 (5w 0) 75 (20 w 5) 0.175^
44  10 (15 w 60) 37  23 (10 w 65) 0.145^
parisons of the demographic data and clinical severity of OA knee were performed
e-way ANOVA (#), KruskaleWallis H test (^) or Chi-square test (*) when appropriate.
not included for comparison. All data were expressed as mean  standard deviation.
Table II
Physical and laboratory examinations of knee OA patients taken from clinical record*
Parameters/Reference values Comorbidities in knee OA patients
No hypertension, no T2DM Hypertension, no T2DM Hypertension and T2DM P value
Systolic blood pressure (mmHg) 95 w 140 119  15 (110 w 138) 135  16 (112 w 174) 132  15 (108w 149) 0.076
Diastolic blood pressure (mmHg) 60 w 90 70  8 (60 w 80) 81  13 (60 w 103) 75  11 (57w 89) 0.129
Calcium (mmol/L) 2.24e2.63 2.33  0.12 (2.16 w 2.51) 2.30  0.12 (2.13w 2.50) 2.30  0.06 (2.23 w 2.38) 0.812
Phosphate (mmol/L) 0.88e1.45 1.05  0.16 (0.85 w 1.25) 1.16  0.21 (0.73w 1.41) 1.05  0.07 (0.99 w 1.16) 0.398
Glucose (mmol/L) <7.8 6.7  1.5 (5.2 w 8.7) 6.3  1.3 (3.7w 8.7) 8.6  3.6 (4.5 w 14.6) 0.085
Total Protein (g/L) 67e87 74  5 (69 w 86) 76  5 (67 w 85) 75  5 (69w 84) 0.778
Albumin (g/L) 39e50 43  2 (39 w 46) 42  4 (33 w 46) 41  3 (34w 44) 0.502
Globulin (g/L) 26e40 32  4 (25 w 40) 34  4 (28 w 43) 34  8 (26w 50) 0.421
ALP (U/L) 47e124 68  12 (47 w 86) 75  21 (42 w 115) 76  24 (50w 119) 0.565
ALT (U/L) 8w 45 24  13 (11 w 53) 21  9 (8 w 36) 25  17 (7w 66) 0.748
AST (U/L) 15e37 27  9 (17 w 47) 25  6 (17 w 35) 26  10 (15w 49) 0.949
Urea (mmol/L) 2.9e8.0 6.0  1.8 (3.7 w 9.6) 7.2  2.9 (2.5w 14.2) 6.3  2.0 (4.6 w 11.0) 0.384
Creatinine (umol/L) 49e82 68  13 (51 w 93) 86  36 (39 w 161) 81  16 (59w 102) 0.260
All data were expressed asmean standard deviation and range in the bracket. The comparisons of physical and laboratory data were performed among the groups of knee OA
patients in presence or absence of hypertension and T2DM using one-way ANOVA.
* The data of 1 patients having T2DM only were listed in supplementary materials but not included for comparison. All data were expressed as mean  standard deviation.
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wanted edges were removed according to their coordinate in the
segmented images. After smoothingprocedure, the selectedROIwas
then input into SkyScan CT analyser for analyses. The following pa-
rameters of subchondral plate: bone volume fraction (BV/TV), bone
mineral density (BMD), total (openplus close) porosityandpore size,
were calculated accordingly. For trabecular bone, a cubic ROI of
10  10  2 mm3 was chosen and the following parameters were
taken, including BV/TV, BMD, trabecular thickness/number/sepa-
ration (Tb.Th, Tb.N, Tb.Sp), structure model index, degree of
anisotropy and connectivity density.
Histological evaluation
After micro-CT scans, the osteochondral plugs were harvested
from the central one third of medial and lateral tibial plateauFig. 1. Micro-CT images of subchondral bone damages in different groups of knee OA patient
no T2DM; Iw L: patient with both hypertension and T2DM). As compared to the knee OA pat
at medial tibial plateau in the patients with hypertension and T2DM (Iw L). BMD, which wa
in these patients (J). Moreover, the thickness of subchondral plate on lateral tibial plateau t
tibial plateau of OA knee; B, F, J: BMD distribution at coronal section view of tibial plateau o
mm3; pink emedium BMD 0.35w 0.55 g/mm3 and yellow e low BMD 0.16w 0.35 g/mm3; C
interest from lateral tibial plateau).respectively, and then processed for histological evaluation. Brieﬂy,
the specimens were decalciﬁed and embedded in wax. The sections
were cut into 5mmthick and stainedwithHematoxylineEosin (H&E).
Statistics analysis
All data were expressed as mean  standard deviation. The
comparisons of the clinical, laboratory and radiological data were
performed among the groups of knee OA patients using one-way
analysis of variance (ANOVA), KruskaleWallis H test or Chi-square
test when appropriate. In addition to the covariates such as the age,
gender and BMI of patients, the comorbidities of knee OA, hyper-
tension and T2DM, were examined as an independent categorical
variable in a multi-variable linear regression model to investigate
their effect on the microstructural damages of subchondral bone.s (Aw D: patient without hypertension or T2DM; Ew H: patient with hypertension but
ients without the comorbidities (Aw D), subchondral bone plate was severely damaged
s coded by different colors, also signiﬁcantly decreased on both medial and lateral sides
urned to be thinner in the subjects with the comorbidities (H, L). (A, E, I: top views of
f OA knee, which are coded in color bar on right corner: red e high BMD 0.55w 1.16 g/
, G, K: cubic regions of interest (ROI) frommedial tibial plateau, D, H, L: cubic regions of
C.Y. Wen et al. / Osteoarthritis and Cartilage 21 (2013) 1716e1723 1719SPSS 20.0 (Chicago, IL, USA)was used for analyses with the statistical
signiﬁcance set at 0.05.
Results
Among all knee OA patients recruited in this study, 79% of them
were overweight or obese. Therewere 63% (27 out of 43) of knee OA
patients having primary hypertension and 30% (13 out of 43) of
them with T2DM. It was noted that 12 out of 13 OA patients with
T2DM co-existed with essential hypertension. OA knee patients
were then divided into three groups for comparisons: Group 1:
subjects without hypertension nor T2DM, Group 2: subjects with
hypertension but no T2DM and Group 3: with both hypertension
and T2DM (Table I). There was only one OA patient having T2DM
but no hypertension, which was listed for the completeness and
transparency of our data but not included for statistical analyses
subsequently (Supplementary Tables IeIII).
Therewere no signiﬁcant differences in the patients’ age, gender
and BMI among three groups. Patients with hypertension andFig. 2. Comparisons of BMD and porosity of medial subchondral bone plate between knee O
subjects without the comorbidities, knee OA patients with hypertension and T2DM showed s
plate on medial tibial plateau. Similar trend was also found in BMD (C, P ¼ 0.042) and total
among the groups were performed using one-way ANOVA and the signiﬁcance level was sT2DM had the worse walking function than the subjects without
the comorbidities (P ¼ 0.051) although they showed the similar
severity of radiological knee OA in terms of KeL grade (Table I).
There existed marginal differences in systolic blood pressure
(P ¼ 0.076) and fast glucose test (P ¼ 0.085) among the groups.
Apart from that, patients with hypertension and diabetes did not
differ from the subjects without these comorbidities regarding the
data from the tests of the electrolytes, liver and renal function
(Table II).
As shown in micro-CT images, signiﬁcant loss of subchondral
bone plate structural integrity onmedial tibial plateau was noted in
knee OA patients with hypertension and T2DM as compared to
those without these comorbidities (Fig. 1). It was accompanied by
full-thickness articular cartilage worn away in these patients
(Fig. 2). Loss of subchondral bone plate integrity was characterized
by the decrease of BMD and an increase of structural porosity
(Fig. 3, Supplementary Table IV). The similar trendwas also found in
subchondral plate at lateral tibial plateau, and underneath trabec-
ular bone on medial tibial plateau showing relatively lower BV/TVA patients in presence or absence of hypertension and T2DM. In comparison with the
igniﬁcantly lower BMD (A, P ¼ 0.034) and higher porosity (B, P ¼ 0.032) at subchondral
porosity (D, P ¼ 0.088) of subchondral plate at lateral tibial plateau. The comparisons
et at P < 0.05.
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tically signiﬁcant (Supplementary Table IV).
The comorbidities in knee OA were categorized as follows: “1”
no hypertension, no T2DM; “2” hypertension, no T2DM; “3” hy-
pertension and T2DM. With the change in the categories of the
comorbidities from 1 to 3, BMD of subchondral plate decreased by
0.312 g/cm3 and the porosity increased by15.347% after fully
adjustment of the covariant (Table III). As shown in Supplementary
Fig.1, BMI correlatedwith BMD of subchondral plate atmedial tibial
plateau (A, P ¼ 0.025). Meanwhile, it was also associated with the
porosity of subchondral plate on medial side of tibial plateau in OA
knees (C, P ¼ 0.031). So BMI could be a confounding factor in the
estimated effect of comorbid diseases on subchondral bone dam-
ages in a regressionmodel. As shown in Table III, the standardized b
weight of the comorbid diseases contributing to BMD of sub-
chondral plate obviously increased from unadjusted 0.577 to
minor adjusted 0.701 by the age, gender and BMI of knee OA
patients. After adjusting the age, gender and BMI, the presence of
hypertension and T2DM was included in a regression model to
contribute in part to the decreased BMD (r2 ¼ 0.551, P ¼ 0.004) and
increased porosity (r2 ¼ 0.545, P ¼ 0.003).Fig. 3. Histological images of osteochondral junction at lateral (A, C, E) and medial (B, D, F) t
and T2DM; C w D: patients with hypertension only; E w F: patients with both hyperten
subchondral bone was severely damaged on medial tibial plateau in patients with hypert
overlying articular cartilage (D, F). Furthermore, the thickness of subchondral bone plate on l
together with the elevated porosity (C, E) (HematoxylineEosin staining).Discussion
The scientiﬁc merit of this study was to put the statistically
signiﬁcant relationship of knee OA with the coexisting hyperten-
sion and diabetes in epidemiological studies under microscopic
examination. Our ﬁndings pave a road to further explore the un-
derlying mechanism of the mutual relationship between knee OA
and its comorbidities. In the present study, we observed signiﬁcant
bone loss at subchondral plate at medial tibial plateau, in terms of
reduced BMD and elevated porosity, in knee OA patients with hy-
pertension and/or T2DM as compared to the subjects without these
comorbidities. Our ﬁndings suggest a potential biological link be-
tween bone loss at subchondral plate in knee OA and its comorbid
diseases. As shown in a linear regression model, the presence of
hypertension and diabetes could explain in part (around 50%) the
decreased BMD and increased porosity of subchondral plate in OA.
This ﬁnding was generated after considering the covariate, such as
the age, gender, and BMI of knee OA patients etc. Among the co-
variate, it was not surprised to ﬁnd the overweight (BMI >24 and
<30) or obesity (BMI 30) in southern Chinese subjects as a con-
founding factor to correlate with BMD and porosity of subchondralibial plateau in knee osteoarthritis (OA) patients (Aw B: patients without hypertension
sion and T2DM). As compared to the subjects without these comorbid diseases (B),
ension and diabetes, which was accompanied by wearing away the full-thickness of
ateral tibial plateau was also obviously thinner in these patients with the comorbidities
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C.Y. Wen et al. / Osteoarthritis and Cartilage 21 (2013) 1716e1723 1721plate. After adjusting these covariates, we can clearly notice the
add-on effect of the comorbidities on the subchondral bone dam-
ages on the top of the major risk factors in the pathomechanism of
knee OA, for example the obesity. To our best knowledge, this is the
ﬁrst time to establish such numerical relationship between sub-
chondral bone microstructural damages in knee OA and its
comorbidities.
The emerging view of knee OA is that part of joint pain and
disorder might be related to altered vascular function19,20,29. The
scenario of the development of OAwith hypertensionwas proposed
as follows: narrow or constricted vessels restrict blood ﬂow to
subchondral bone, and impair the circulation and nutrition supply
to overlying articular cartilage, and ultimately contribute to the
deterioration of cartilage degeneration in OA30.
This hypothetic model for vascular pathology in pathomechan-
ism of OAwas supported by a recent epidemiological study showing
a novel relationship between arterial stiffness with development of
hand OA29. Our ﬁndings enriched this hypothetic model that high
blood pressure might contribute to the decreased BMD at sub-
chondral plate in knee OA. As a consequence, subchondral plate
with low bone mass might be susceptible for microcrack or micro-
fracture at osteochondral junction under repetitive mechanical
loading during jointmovement, which in turn triggers or aggregates
the development of OA31. It was compatible with previous ﬁndings
on the association of high blood pressure with low bone mass and
high risk of fracture in general population23e25.
T2DM is another disease having a strong relationship with knee
OA16,21,32,33. In a recent study, 927 men and women at the age of
40e80 years old were studied by a 20-year follow-up33. It was
found that type 2 diabetes emerged as an independent risk pre-
dictor for arthroplasty after adjustment for age, BMI, and other risk
factors for OA33. In addition, the subjects with diabetes developed
more severe clinical symptoms of OA (Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC) score) and
structural joint damages in terms of joint effusion and synovitis
under ultrasonography33. Researchers concluded that type 2 dia-
betes predicted the development of severe OA independent of age
and BMI33. However, they did not provide any information
regarding articular cartilage degeneration and subchondral bone
abnormality, which are the primary concern in knee OA,
in presence of type 2 diabetes. Our ﬁndings contributed to ﬁll out
this research gap. We observed more severe subchondral plate and
articular cartilage damages in knee OA patients with type 2 dia-
betes and hypertension as compared to the subjects without these
comorbidities. These ﬁndings further strengthen the concept of a
strong metabolic component in the pathogenesis of OA.
There were two possible pathways for T2DM involved in the
pathogenesis of OA. Firstly, the insulin resistance in T2DM might
trigger the cascade inﬂammatory reactions21,34e36, which is known
to play an important role in the development of OA37. On the other
hand, inﬂammation produces C-reactive protein (CRP), which, un-
fortunately, can damage the arteries by helping to form plaque
while attempting to tackle a long-term condition like high blood
pressuree often an accompanying T2DM38. In the case series of this
study, we found that the majority of knee OA patients with T2DM
(12 out of 13) also had essential hypertension. This likely means
that paying attention to insulin resistance, and high blood pressure
could be important in preventing the progression of OA.
Clinical management of knee OA, hypertension and T2DM in the
elderly patients is a dilemma for clinicians because of the complex
interaction among them. It was known that NSAIDs, widely used for
pain management in knee OA, induce high blood pressure in OA
patients39. In addition, some anti-hypertensive medicines were
known to aggregate bone loss40. The ﬁndings generated from this
study raise the public awareness on the phenomenon of bone loss
C.Y. Wen et al. / Osteoarthritis and Cartilage 21 (2013) 1716e17231722at subchondral plate of OA knee in presence of hypertension and
type 2 diabetes. Understanding of the interrelationship between
subchondral bone loss in OA and its comorbidities would bring the
hope to break down the vicious cycle in management of the elderly
persons with these multiple organ disorders.
The pores in subchondral plate at osteochondral junction are
necessary for nutrition supply, and exchanges of metabolites be-
tween subchondral bone and overlying articular cartilage3. Previ-
ous study has identiﬁed the increase of the pore size in subchondral
plate and the decrease of bone mass together with the develop-
ment of OA-like changes induced by collagenase in a mice model41.
The increased porosity of subchondral plate at osteochondral
junction might facilitate the invasion of the heterozygous clustered
bone marrow cells, including multi-nucleated cells, and blood
vessel (Supplementary Figs. 2 and 3). As a consequence, the in-
growth of blood vessels and bone marrow cells might trigger the
endochondral ossiﬁcation in the hyaline cartilage, lead to the
stiffening of cartilage collagen ﬁbrils42, ultimately the failure of
articular cartilage.
There are several major limitations in the current study. First,
the cross-sectional observation in a case series study does not allow
us to answer any question regarding the causative effect of the
comorbidities on knee OA, or vice versa. Second, the sample number
was relative small and we only analyzed two most frequently
encountered comorbidities in knee OA: hypertension and T2DM,
but did not cover all the other comorbidities, for example hyper-
lipidemia, chronic ischemic heart disease, atherosclerosis and
stroke etc. Third, the clinical and laboratory data were taken from
clinical record, and the non-routine examinations, such as the
PWV/ABI data for arterial stiffening, were not available. Some re-
cord on the duration of diseases and all treatments for the
comorbidities were incomplete although the latest medications,
previous cardiovascular events or diabetes complications were well
documented. Last but not least, there are many more potential
confounders in the observed associations and the potential of re-
sidual confounding factors might bring the bias due to incomplete
adjustment.
We appreciated that knee OA is a multifactorial disorder and
only 43 human subjects were analyzed in the present study. Here,
we mainly reported a phenomenon that bone loss occurred at
subchondral plate of OA knee in presence of hypertension and
T2DM. Our further analyses imply the biological link between
subchondral bone loss in knee OA and its comorbid diseases. By
doing that, we hope to raise the public awareness of their complex
interactions in elderly persons, and prompt the needs of a large-
scale cohort study to conﬁrm the causality between them.
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